February 6, 2019

Improving Alzheimer’s Disease Management: Early Diagnosis and Health Equity Considerations

Hybrid 2021 Alzheimer’s Association International Conference (AAIC)

Early Detection of AD in Clinical Practice: Overcoming Challenges

In this section, Ellen Woo, PhD, highlights the importance of clinical assessment for early detection of AD. She first describes clinical staging before delving into the domains (functional, cognitive, and behavioral) impacted in AD and the tools commonly used in the clinic to detect deficits in these domains. Dr. Woo then outlines some of the challenges and key considerations for implementing cognitive assessments in routine clinical practice, including potential barriers imposed by language, cultural influences, and level of education.

Key Learning Objectives from Biogen’s AAIC 2021 Symposium:

  • Highlight the importance of early detection and diagnosis of AD, through appropriate use of cognitive and functional screening tools and biomarker assessments
  • Assess current healthcare system readiness for a paradigm shift to early diagnosis of AD
  • Outline considerations in patient care for underrepresented and underserved populations

Disclosure: All panelists received honoraria from Biogen for participation in this symposium.

Disclaimer: All of the information discussed today is for informational purposes only; does not constitute medical advice; and is not intended to be a substitute for independent professional medical judgment, advice, diagnosis, or treatment.